Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C1147T/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
C319G/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine and upper reaspiratory infections
C319T
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
C319T/G1095T
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
C488A/C988T
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine and reactive airway disease
C527A/T1164/G1165del/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
C867A
-
naturally occuring homozygote mutation, genotype, mutant shows increased isobutyrylcarnitine levels in the urine
E344G
site-directed mutagenesis, the SCAD mutant shows reduced activity compared to the wild-typ enzyme, but does not influence the wild-type SCAD activity when co-transfected in HEK-293 cells
E368G
-
is unable to form a charge-transfer complex with substrate/product, does not efficiently compete with the wild-type enzyme for the physiological electron acceptor
E368Q
-
inactivates the reductive and oxidative pathways
G108D
site-directed mutagenesis, the SCAD mutant shows reduced activity compared to the wild-typ enzyme, but does not influence the wild-type SCAD activity when co-transfected in HEK-293 cells
G1095T/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
G1153T/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
G209S
-
mutant shows a temperature-dependent production of SCAD tetramers with reduced amounts compared to the wild type enzyme
G268A/1C147T/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
G268A/C1147T/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
G320A/G417C
-
naturally occuring mutation, genotype, mutant shows highly increased acylglycines and organic acid levels in the urine and eczema
G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
G682/A683del/C988T
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
P55L
site-directed mutagenesis, the SCAD mutant shows reduced activity compared to the wild-typ enzyme, but does not influence the wild-type SCAD activity when co-transfected in HEK-293 cells
R107C
-
naturally occuring mutation, development of a cell model system, stably expressing either the SCAD wild-type protein or the misfolding SCAD variant protein, R107C, genotype C319T. The model system is used for investigation of SCAD with respect to expression, degree of misfolding, and enzymatic SCAD activity
R171W
-
mutant shows a temperature-dependent production of SCAD tetramers with reduced amounts compared to the wild type enzyme
T455C/T443T
-
naturally occuring mutation, genotype, mutant shows increased isobutyrylcarnitine levels in the urine, and pyelonephritisand emesis
T529C
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine
T529C/G625A
-
naturally occuring mutation, genotype, mutant shows increased acylglycines and organic acid levels in the urine and atrial septal defect
E367Q
-
mutant enzyme shows less than 0.03% of the activity seen in normal cloned enzyme, E367 is responsible for catalytic activity
E368D
-
mutant exhibits enzyme activity
E368G
-
inactive enzyme, E368 is responsible for catalytic activity
E368G/G247E
-
mutant exhibits enzyme activity
E368L
-
inactive enzyme, E368 is responsible for catalytic activity
E368Q
-
inactive enzyme, E368 is responsible for catalytic activity
E368R
-
inactive enzyme, E368 is responsible for catalytic activity
G185S
-
58% of wild-type activity at 41°C after expression in COS-7 cells, mutation may confer susceptibility to accumulation of ethylmalonic acid in affected individuals
G185S
-
80% of wild-type kcat with butanoyl-CoA
G185S
-
impairments of both its kinetic and electron transfer properties
G185S
-
the mutant is not detected at protein level but shows high mRNA levels
G185S
-
625G>A polymorphism
R147W
-
135% of wild-type kcat with butanoyl-CoA
R147W
-
45% and 13% of wild-type activity at 37°Cand 41°C, respectively, after expression in COS-7 cells, mutation may confer susceptibility to accumulation of ethylmalonic acid in affected individuals
R147W
-
exhibits almost identical physical and redox properties to wild-type but only half of the specific activity and substrate activation shifts observed in wild-type enzyme
R147W
-
511C>T polymorphism
R83C
-
the mutant enzyme does not form tetramers and is inactive
R83C
-
unable to form tetramers, soluble mutant enzyme is not detected at steady-state
R83C
-
a naturally occuring mutation, c.319C>T, of SCAD involved in SCAD deficiency, SCADD
additional information
-
disruption of the scdA gene results in 7.5fold reduction in butyryl-CoA dehydrogenase activity
additional information
-
coupled gene mutations G625A and C511T impair C4-C6 fatty acid metabolism and variably causes neonatal/infantile hypotonia with developmental delays
additional information
-
knockdown of HADHSC expression by RNA interference in INS832/13 beta-cells using short hairpin RNA and short interference RNA